New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release. 

Contact Us

Classification of high versus low annualized relapse rate status in subjects with relapsing-remitting multiple sclerosis using multivariate serum protein biomarker models

February 14, 2022inByCommentNo Comments
Click here

© 2025 Octave Bioscience, Inc | 1440 O’Brien Drive, Suite B, Menlo Park, CA 94025 

Connect with us